-
The advisory committee on immunization practices (APIC) and the CDC have updated for the use of the 23 valent pneumococcal polysaccharide vaccine (PPSV23) for the prevention of invasive pneumococcal disease in adults.
-
With antimicrobial resistance among clinical bacterial isolates becoming a greater problem with each passing year, the need for novel antibacterial agents has become more urgent than ever.
-
In countries endemic for malaria, young children often receive empiric antimalarial therapy for febrile illness, resulting in over treatment and expense.
-
-
For patients presenting with acute coronary syndromes (ACS), the optimal doses of aspirin and clopidogrel remain unknown.
-
Despite impressive reductions in cardiovascular risk in primary and secondary prevention trails with statin therapy, risk does not reach zero.
-
Merlin-timi 36 tested the hypothesis that ranolazine, a recently approved anti-anginal agent, would benefit patients with non-ST-elevation acute coronary syndrome (NSTEACS).
-
In this report, Liu and colleagues describe the electrophysiologic characteristics of atrial tachycardias (AT) that arise from the noncoronary aortic sinus (NCAS).
-
Supraventricular tachycardia (SVT) is known to be associated with troponin leaks and ST-wave depression on ECG, both potential markers of ischemia.
-
Patients with extensive coronary artery disease (CAD) and left ventricular (LV) dysfunction are at high risk during revascularization.
